Patent details
EP2112162 Title: Genetically modified human natural killer cell lines
Basic Information
- Publication number:
- EP2112162
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP091648048
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Genetically modified human natural killer cell lines
- French Title of Invention:
- Lignées de cellules tueuses naturelles humaines génétiquement modifiées
- German Title of Invention:
- Genetisch modifizierte, menschliche, natürliche Killerzellellinien
- SPC Number:
Dates
- Filing date:
- 08/07/2005
- Grant date:
- 14/01/2015
- EP Publication Date:
- 14/01/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/10/2009
- EP B1 Publication Date:
- 14/01/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/07/2015
- Expiration date:
- 08/07/2025
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 08/07/2005
- Name:
- FOX CHASE CANCER CENTER
- Address:
- 333 Cottman Avenue, Philadelphia, PA 19111-2497, United States (US)
Inventor
- Name:
- Campbell Kerry S.
- Address:
- United States (US)
Priority
- Priority Number:
- 586581 P
- Priority Date:
- 10/07/2004
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 14/705;
Publication
European Patent Bulletin
- Issue number:
- 201833
- Publication date:
- 15/08/2018
- Description:
- Termination of the opposition
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|